Evidence map›Paper›PMID 32633599›Full record

ArticlePublic health reports (Washington, D.C. : 1974)

Trends in Indicators of Injection Drug Use, Indian Health Service, 2010-2014 : A Study of Health Care Encounter Data.

Mary E Evans, Marissa Person, Brigg Reilley, Jessica Leston, Richard Haverkate, Jeffrey T McCollum, Andria Apostolou, Michele K Bohm, Michelle Van Handel, Danae Bixler and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in Public health reports (Washington, D.C. : 1974). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 3 institutions in 1 country.

Mary E Evans1242 Division of Unintentional Injury Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Marissa PersonDivision of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Brigg Reilley23762 Northwest Portland Area Indian Health Board, Portland, OR, USA.
Jessica Leston23762 Northwest Portland Area Indian Health Board, Portland, OR, USA.
Richard Haverkate426227 Indian Health Service, Rockville, MD, USA.
Jeffrey T McCollum426227 Indian Health Service, Rockville, MD, USA.
Andria Apostolou426227 Indian Health Service, Rockville, MD, USA.ORCID 0000-0003-2440-9700
Michele K Bohm1242 Division of Unintentional Injury Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Michelle Van Handel2510 National Centers for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Danae Bixler1242 Division of Viral Hepatitis, National Centers for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Andrew J MitschDivision of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Dana L HaberlingDivision of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Sarah M HatcherEpidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA, USA.ORCID 0000-0002-4967-3463
Thomas Weiser1246 Indian Health Service, Portland, OR, USA.
Kim ElmoreDivision of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Eyasu H Teshale1242 Division of Viral Hepatitis, National Centers for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Paul J WeidleDivision of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Philip J PetersDivision of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Kate BuchaczDivision of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.ORCID 0000-0001-5335-5217
Centers for Disease Control and Prevention · USIndian Health Service · USNorthwest Portland Area Indian Health Board · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesHepatitis C virus (HCV) and HIV transmission in the United States may increase as a result of increasing rates of opioid use disorder (OUD) and associated injection drug use (IDU). Epidemiologic trends among American Indian/Alaska Native (AI/AN) persons are not well known.

methodsWe analyzed 2010-2014 Indian Health Service data on health care encounters to assess regional and temporal trends in IDU indicators among adults aged ≥18 years. IDU indicators included acute or chronic HCV infection (only among adults aged 18-35 years), arm cellulitis and abscess, OUD, and opioid-related overdose. We calculated rates per 10 000 AI/AN adults for each IDU indicator overall and stratified by sex, age group, and region and evaluated rate ratios and trends by using Poisson regression analysis.

resultsRates of HCV infection among adults aged 18-35 increased 9.4% per year, and rates of OUD among all adults increased 13.3% per year from 2010 to 2014. The rate of HCV infection among young women was approximately 1.3 times that among young men. Rates of opioid-related overdose among adults aged <50 years were approximately 1.4 times the rates among adults aged ≥50 years. Among young adults with HCV infection, 25.6% had concurrent OUD. Among all adults with arm cellulitis and abscess, 5.6% had concurrent OUD.

conclusionsRates of HCV infection and OUD increased significantly in the AI/AN population. Strengthened public health efforts could ensure that AI/AN communities can address increasing needs for culturally appropriate interventions, including comprehensive syringe services programs, medication-assisted treatment, and opioid-related overdose prevention and can meet the growing need for treatment of HCV infection.

Indexed as

American Indian or Alaska NativeHepatitis COpioid-Related DisordersSubstance Abuse, IntravenousUnited States Indian Health ServiceAdolescentAdultAgedAged, 80 and overFemaleForecastingHumansMaleMiddle AgedUnited StatesYoung AdultAmerican Indian/Alaska Nativehepatitis CHIVinjection drug useopioid use disorder

Identifiers

PMID32633599
PMCPMC7383762
OpenAlexW3042058824

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.